Contact
Please use this form to send email to PR contact of this press release:
Novaliq Provides Development Update on CyclASol Topical Ophthalmic Solution for the Treatment of Dry Eye Disease
TO:
Simone Angstmann-Mehr
Novaliq GmbH
+49 6221 502590